1-2 of 2
Xiaopeng Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of factors from established prognostic models in patients with chronic lymphocytic leukemia (CLL) treated with zanubrutinib: A post-hoc analysis of two phase 3 studies (SEQUOIA and ALPINE)

Free
Jessica Li, Yang Shi, Linlin Xu, Xiaopeng Ma, Marcus Lefebure, Tommi Salmi, Teiko Sumiyoshi, Inhye Ahn
Journal: Blood
Blood (2025) 146 (Supplement 1): 5681.
https://doi.org/10.1182/blood-2025-5681
Published: 2025
Journal Articles

Biomarker Analysis of Zanubrutinib and Tislelizumab Combination Therapy in Patients with Relapsed/Refractory B-Cell Malignancies

Free
Jiaoyan Lyu, Xiaopeng Ma, Ruiqi Huang, Liyun Zhao, Yiling Yu, Oscar Puig, Yang Liu, James Hilger
Journal: Blood
Blood (2022) 140 (Supplement 1): 3521–3522.
https://doi.org/10.1182/blood-2022-168474
Published: 2022